Patents by Inventor Andrew C. Hayes

Andrew C. Hayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9320471
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: April 26, 2016
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20120259278
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Application
    Filed: June 21, 2012
    Publication date: October 11, 2012
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20120227737
    Abstract: An analyte sensor and systems for determining analyte levels in a user's body. The analyte sensor and systems are adapted to be used with single dose medication devices and include a communication system to transmit the communications from the analyte sensor to the user to notify the user of an estimated amount of fluid to deliver to the user's body. More particularly, these apparatuses and methods for use are for providing convenient monitoring of blood glucose levels in determining the appropriate amount of insulin to deliver.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 13, 2012
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: JOHN J. MASTROTOTARO, Rajiv Shah, Partha Ray, Kenny J. Long, Andrew C. Hayes, Nandita Patel, Cary D. Talbot, Bahar Reghabi
  • Patent number: 8226556
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: July 24, 2012
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20100274592
    Abstract: A diabetes data management system selects variable parameters and one or more devices with data that are utilized in a report. The diabetes data management system analyzes data during a selected period. The system generates reports which highlight data from one or more device during the selected period including carbohydrate, insulin, and glucose data, reports which highlight data around and during meal events and other user-defined events, reports which overlay multiple data based on time of day and other factors, and automatically prepared logbook reports.
    Type: Application
    Filed: June 25, 2010
    Publication date: October 28, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Tamir Nitzan, Jon Plummer, Joel Goldsmith, John J. Mastrototaro, Alan O. Marcus, Andrew C. Hayes, Matt Glidden, Gabe Cortina
  • Publication number: 20100217178
    Abstract: A method for peritoneal dialysis treatment includes (i) predicting results of a plurality of patient therapy outcomes for a plurality of different mixed dextrose level dialysis solutions; (ii) selecting one of the mixed dextrose level solutions for a patient based on the results; and (iii) performing at least one therapy using different unmixed dextrose level solutions that combine to simulate a like cumulative concentration that would be achieved using the selected mixed dextrose level solution.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 26, 2010
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Ying-Cheng Lo, Alp Akonur, Isaac Martis, Andrew C. Hayes
  • Publication number: 20090234213
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Application
    Filed: May 6, 2009
    Publication date: September 17, 2009
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Patent number: 7547281
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Grant
    Filed: December 30, 2005
    Date of Patent: June 16, 2009
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
  • Publication number: 20080139910
    Abstract: An analyte sensor and systems for determining analyte levels in a user's body. The analyte sensor and systems are adapted to be used with single dose medication devices and include a communication system to transmit the communications from the analyte sensor to the user to notify the user of an estimated amount of fluid to deliver to the user's body. More particularly, these apparatuses and methods for use are for providing convenient monitoring of blood glucose levels in determining the appropriate amount of insulin to deliver.
    Type: Application
    Filed: December 6, 2006
    Publication date: June 12, 2008
    Applicant: METRONIC MINIMED, INC.
    Inventors: John J. Mastrototaro, Rajiv Shah, Partha Ray, Kenny J. Long, Andrew C. Hayes, Nandita Patel, Cary D. Talbot, Bahar Reghabi
  • Patent number: D390959
    Type: Grant
    Filed: November 26, 1996
    Date of Patent: February 17, 1998
    Assignee: Acuson Corporation
    Inventors: Robert Mesaros, Richard W. Henderson, William J. Park, Kathleen A. Ruvolo, Janice L. Marshall, Andrew C. Hayes